µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå ºÐ¼®°ú ¿¹Ãø(-2033³â) : À¯Çü, Á¦Ç°, ¼­ºñ½º, ±â¼ú, ÄÄÆ÷³ÍÆ®, ¿ëµµ, µµÀÔ, ÃÖÁ¾»ç¿ëÀÚº°
Digital Pathology Solutions Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Component, Application, Deployment, End User
»óǰÄÚµå : 1632765
¸®¼­Ä¡»ç : Global Insight Services LLC
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 382 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,750 £Ü 6,872,000
Single User License help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇϸç, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 5,750 £Ü 8,319,000
Site License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(±¹°¡)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,750 £Ü 9,766,000
Enterprise License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ Àü ¼¼°è ¸ðµçºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀåÀº CAGR ¾à 15.5%¸¦ ¹Ý¿µÇϸç, 2024³â 15¾ï ´Þ·¯¿¡¼­ 2034³â¿¡´Â 63¾ï ´Þ·¯·Î È®´ëÇÒ Àü¸ÁÀÔ´Ï´Ù.

µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå¿¡´Â ÀüÅëÀûÀÎ º´¸®ÇÐ ¿öÅ©Ç÷οìÀÇ µðÁöÅÐÈ­¸¦ ÃËÁøÇÏ´Â ±â¼ú°ú ¼­ºñ½º°¡ Æ÷ÇԵ˴ϴÙ. µðÁöÅÐ À̹ÌÁö ó¸®, À̹ÌÁö ºÐ¼® ¼ÒÇÁÆ®¿þ¾î, µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛ µîÀÌ Æ÷ÇԵǾî Áø´ÜÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ³ôÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀº ¿ø°Ý º´¸® Áø´ÜÀ» Áö¿øÇÏ°í ¿ø°Ý Áø·á ¹× °øµ¿ ÀÛ¾÷À» °¡´ÉÇϰÔÇÏ¸ç °³ÀÎÈ­µÈ ÀÇ·á, ¿¬±¸ ¹× ±³À° ±¸»óÀ» ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»Çϸ纸´Ù ÅëÇյǰí È®Àå °¡´ÉÇÑ ÀÇ·á ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀ» ¹Ý¿µÇÕ´Ï´Ù.

µðÁöÅÐ º´¸® ¼Ö·ç¼Ç ½ÃÀåÀº ±â¼ú ¹ßÀü°ú ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ Ã¤Åà Áõ°¡·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Ȧ½½¶óÀ̵å À̹Ì¡Àº º´¸® ½½¶óÀ̵åÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®°ú °íÇØ»óµµ µðÁöÅÐÈ­¸¦ Á¦°øÇÏ¿© ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ½ºÄ³³Ê¿Í ½ºÅ丮Áö ¼Ö·ç¼ÇÀ» Æ÷ÇÔÇÑ Çϵå¿þ¾î ºÎ¹®Àº ½Å·ÚÇÒ ¼ö ÀÖ°í È¿À²ÀûÀÎ µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ¹Ý¿µÇÏµí µÎ ¹øÂ°·Î ³ôÀº ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ µðÁöÅÐ ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ¿Í ¿ìÈ£ÀûÀÎ ±ÔÁ¦ Á¤Ã¥ÀÇ ÇýÅÃÀ» ´©¸®¸ç ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. À¯·´Àº Á¤¹ÐÀÇ·á¿Í º´¸® ¿öÅ©Ç÷ο쿡 AI¸¦ ÅëÇÕÇÏ´Â µ¥ ÁßÁ¡À» µÎ°í ÀÖÀ¸¸ç, À̸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç, ƯÈ÷ Áß±¹°ú Àεµ´Â ÀÇ·áºñ Áõ°¡¿Í ÀÇ·á ½Ã¼³ Çö´ëÈ­¿¡ ´ëÇÑ °ü½É Áõ°¡·Î ÀÎÇØ À¯¸®ÇÑ ±âȸ·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ½ÃÀåÀÇ ¿ªµ¿ÀûÀΠƯ¼º°ú ´Ù¾çÇÑ Áö¿ª¿¡ °ÉÃÄ Áö¼ÓÀûÀ¸·Î È®´ëµÉ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

2023³â µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀåÀº Àü ¼¼°è¿¡¼­ 3¾ï 2,000¸¸ ½½¶óÀ̵åÀÇ °ß°íÇÑ ºÐ¼®·®À» ±â·ÏÇÒ °ÍÀ̸ç, 2033³â¿¡´Â 5¾ï 8,000¸¸ ½½¶óÀ̵忡 ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ȧ ½½¶óÀ̵å À̹Ì¡ ½Ã½ºÅÛÀÇ º¸±Þ¿¡ ÈûÀÔ¾î Çϵå¿þ¾î ºÐ¾ß°¡ 45%·Î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÌ 35%·Î ±Ù¼ÒÇÑ Â÷ÀÌ·Î µÚ¸¦ À̾úÀ¸¸ç, AI ±â¹Ý Áø´Ü ÅøÀÇ ¹ßÀüÀÌ ±× µÚ¸¦ ÀÕ°í ÀÖ½À´Ï´Ù. ÄÁ¼³ÆÃ ¹× À¯Áöº¸¼ö¸¦ Æ÷ÇÔÇÑ ¼­ºñ½º ºÎ¹®Àº ½ÃÀå Á¡À¯À²ÀÇ 20%¸¦ Â÷ÁöÇÕ´Ï´Ù. ¿ø°Ý Áø´Ü ¹× ¿ø°Ý º´¸®Çп¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ƯÈ÷ Àü¹® ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇÑÀûÀÎ Áö¿ª¿¡¼­ Å« ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ´Â ¶óÀÌÄ«¹ÙÀÌ¿À½Ã½ºÅÛÁî, Philips ÇコÄɾî, ·Î½´Áø´Ü µî ÁÖ¿ä ±â¾÷ÀÌ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ Áö¼ÓÀûÀ¸·Î Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ƯÈ÷ FDA¿Í À¯·´ÀǾàǰû(EMA)ÀÌ Á¦Á¤ÇÑ ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå ¿ªÇп¡ Å« ¿µÇâÀ» ¹ÌÄ¡¸ç, µ¥ÀÌÅÍ º¸¾È°ú »óÈ£¿î¿ë¼º Ç¥ÁØÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ¿Í Àü·«Àû Á¦ÈÞ°¡ ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ°í ½ÃÀå È®´ëÀÇ ±âȸ°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á¿Í ³ôÀº Ãʱ⠺ñ¿ë µîÀÇ °úÁ¦°¡ ³²¾ÆÀÖÁö¸¸, Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç°ú AIÀÇ ÅëÇÕÀº À¯¸ÁÇÑ ¼ºÀå °æ·Î¸¦ Á¦½ÃÇÕ´Ï´Ù.

ºÏ¹Ì´Â ÁÖ·Î ¹Ì±¹ÀÌ ÁÖµµÇÏ´Â µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸®´õ½ÊÀº ¹Ì±¹ÀÇ ÅºÅºÇÑ ÀÇ·á ÀÎÇÁ¶ó¿Í ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ¿¡ ÈûÀÔÀº ¹Ù Å®´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í ¿¬±¸°³¹ß¿¡ ´ëÇÑ °­·ÂÇÑ ÁýÁßÀº ±× ÁöÀ§¸¦ ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù. ij³ª´Ù´Â µðÁöÅÐ ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ µµÀÔ È®´ë¿¡µµ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

À¯·´¿¡¼­´Â µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º¸¦ ÇʵηΠ½ÃÀåÀÌ ²ÙÁØÈ÷ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ±¹°¡´Â Áø´ÜÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ³ôÀ̱â À§ÇØ µðÁöÅÐ º´¸® °Ë»ç¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº Á¤ºÎÀÇ Àû±ØÀûÀÎ Áö¿ø°ú µðÁöÅÐ º´¸® Áø´ÜÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº µðÁöÅÐ ÆÐÇ÷Áõ ¼Ö·ç¼ÇÀÇ À¯¸®ÇÑ ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. Áß±¹, ÀϺ», Àεµ¿Í °°Àº ±¹°¡µéÀº ÀÇ·á ÀÎÇÁ¶ó¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í È¿À²ÀûÀÎ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº Àα¸°¡ ¸¹°í, µðÁöÅÐÈ­¿¡ ´ëÇÑ ³ë·ÂÀÌ È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖ´Â °Íµµ Å« ±â¿©¸¦ Çϰí ÀÖ½À´Ï´Ù.

ºê¶óÁú°ú ¸ß½ÃÄÚ¸¦ ÇʵηΠÇÑ ¶óƾ¾Æ¸Þ¸®Ä«´Â À¯¸ÁÇÑ ÀáÀç·ÂÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ÷´Ü ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Áø´Ü Á¤È®µµ Çâ»ó¿¡ ´ëÇÑ Çʿ伺ÀÌ µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó¸¦ °­È­ÇÏ·Á´Â Á¤ºÎÀÇ ±¸»óÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­´Â µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç µµÀÔÀÌ Á¡Â÷ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ³²¾ÆÇÁ¸®Ä«°øÈ­±¹°ú ¾Æ¶ø¿¡¹Ì¸®Æ®°¡ ÁÖ¿ä ±â¿©±¹ÀÔ´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í Áø´Ü ´É·Â Çâ»ó¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå¿¡ °üÇÑ ÁÖ¿ä ÀλçÀÌÆ®

Á¦4Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå Àü¸Á

Á¦5Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå Àü·«

Á¦6Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð

Á¦7Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå : À¯Çüº°

Á¦8Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå : Á¦Ç°º°

Á¦9Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå : ¼­ºñ½ºº°

Á¦10Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå : ±â¼úº°

Á¦11Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

Á¦12Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå : ¿ëµµº°

Á¦13Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå : µµÀÔº°

Á¦14Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦15Àå µðÁöÅÐ º´¸®ÇÐ ¼Ö·ç¼Ç ½ÃÀå : Áö¿ªº°

Á¦16Àå °æÀï ±¸µµ

Á¦17Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Digital Pathology Solutions Market is poised to expand from $1.5 billion in 2024 to $6.3 billion by 2034, reflecting a CAGR of approximately 15.5%.

The Digital Pathology Solutions Market encompasses technologies and services facilitating the digitization of traditional pathology workflows. It includes digital imaging, image analysis software, and data management systems, enhancing diagnostic accuracy and efficiency. This market supports telepathology, enabling remote consultations and collaborations, and plays a crucial role in advancing personalized medicine, research, and educational initiatives, reflecting a shift towards more integrated and scalable healthcare solutions.

The Digital Pathology Solutions Market is witnessing robust growth, driven by technological advancements and increasing adoption in healthcare. Whole slide imaging dominates the market, offering comprehensive analysis and high-resolution digitization of pathology slides, followed closely by image analysis informatics, which enhances diagnostic accuracy through advanced algorithms. The hardware segment, encompassing scanners and storage solutions, is the second-highest performing, underscoring the demand for reliable and efficient data management systems. Regionally, North America leads the market, benefiting from substantial investments in digital healthcare infrastructure and favorable regulatory policies. Europe follows, propelled by a strong emphasis on precision medicine and the integration of AI in pathology workflows. The Asia-Pacific region, particularly China and India, is emerging as a lucrative opportunity, driven by increasing healthcare expenditure and a growing focus on modernizing medical facilities. These trends highlight the market's dynamic nature and its potential for continued expansion across diverse geographies.

In 2023, the Digital Pathology Solutions Market witnessed a robust volume of 320 million slides analyzed globally, with projections to reach 580 million slides by 2033. The hardware segment commands the largest market share at 45%, driven by the widespread adoption of whole slide imaging systems. Software solutions follow closely at 35%, benefiting from advancements in AI-driven diagnostic tools. Services, including consulting and maintenance, account for 20% of the market share. The increasing demand for remote diagnostics and telepathology is a significant growth catalyst, especially in regions with limited access to specialized healthcare facilities.

The competitive landscape is dominated by key players such as Leica Biosystems, Philips Healthcare, and Roche Diagnostics. These companies are continually enhancing their product portfolios to maintain a competitive edge. Regulatory frameworks, particularly those established by the FDA and the European Medicines Agency, significantly influence market dynamics, emphasizing data security and interoperability standards. Investment in R&D and strategic collaborations are expected to drive innovation, offering lucrative opportunities for market expansion. Challenges persist, including data privacy concerns and high initial costs, but the integration of cloud-based solutions and AI presents promising avenues for growth.

The North American region dominates the digital pathology solutions market, primarily driven by the United States. This leadership is fueled by the country's robust healthcare infrastructure and significant investments in medical technology. The presence of key market players and a strong focus on research and development further bolster its position. Canada also contributes, with its growing adoption of digital healthcare solutions.

In Europe, the market is experiencing steady growth, with Germany, the United Kingdom, and France at the forefront. These countries are embracing digital pathology to enhance diagnostic accuracy and efficiency. The region benefits from favorable government initiatives and increasing awareness about the advantages of digital pathology.

Asia Pacific is emerging as a lucrative market for digital pathology solutions. Countries like China, Japan, and India are investing heavily in healthcare infrastructure. The rising prevalence of chronic diseases and the need for efficient diagnostic solutions drive market expansion. The region's large population base and growing digitalization efforts also contribute significantly.

Latin America shows promising potential, with Brazil and Mexico leading the way. The adoption of digital pathology solutions is driven by the growing demand for advanced healthcare services and the need to improve diagnostic accuracy. Government initiatives to enhance healthcare infrastructure further support market growth.

The Middle East and Africa region is gradually adopting digital pathology solutions. South Africa and the United Arab Emirates are key contributors. The market growth is supported by increasing investments in healthcare infrastructure and a rising focus on improving diagnostic capabilities.

Key Companies

Visiopharm, Indica Labs, Optra SCAN, Hamamatsu Photonics, Inspirata, Proscia, Path AI, Sectra, Corista, Glencoe Software, Objective Pathology Services, Visi Cell Medical, Motic Digital Pathology, 3D HISTECH, Mikroscan Technologies, Paige, Huron Digital Pathology, Konfoong Biotech International, Grundium, Deep Bio

Sources

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), European Society for Digital and Integrative Pathology (ESDIP), Digital Pathology Association (DPA), European Commission - Health and Food Safety, U.S. Food and Drug Administration (FDA), World Health Assembly, International Agency for Research on Cancer (IARC), World Congress on Pathology, American Society for Investigative Pathology (ASIP), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), International Society for Laboratory Hematology (ISLH), United Nations - Department of Economic and Social Affairs, Global Digital Health Partnership (GDHP), American Society for Clinical Pathology (ASCP), International Conference on Digital Pathology, International Society of Digital Pathology (ISDP), Health Level Seven International (HL7), International Conference on Pathology and Digital Pathology

Research Scope

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Digital Pathology Solutions Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Digital Pathology Solutions Market Outlook

5: Digital Pathology Solutions Market Strategy

6: Digital Pathology Solutions Market Size

7: Digital Pathology Solutions Market, by Type

8: Digital Pathology Solutions Market, by Product

9: Digital Pathology Solutions Market, by Services

10: Digital Pathology Solutions Market, by Technology

11: Digital Pathology Solutions Market, by Component

12: Digital Pathology Solutions Market, by Application

13: Digital Pathology Solutions Market, by Deployment

14: Digital Pathology Solutions Market, by End User

15: Digital Pathology Solutions Market, by Region

16: Competitive Landscape

17: Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â